Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
Clinical trial NCT07637851 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07637851
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-09-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.